Cytokinetics | CYTK - Loan Capital


Cytokinetics reported $247.21M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Amgen USD 51.89B 1.88B Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Biogen USD 6.29B 1.7M Mar/2026
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cytokinetics USD 247.21M 868.77M Mar/2026
Eisai JPY 134.78B 12M Mar/2026
Eli Lilly USD 39.37B 1.5B Mar/2026
Geron USD 119.83M 286K Mar/2026
Halozyme Therapeutics USD 1.94B 206.73M Mar/2026
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
Ligand Pharmaceuticals USD 446.19M 702K Dec/2025
Merck USD 46.67B 77M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026